Skip to main content

Hiv-1 Neuropathogenesis and Abused Drugs

Current Views, Problems, and Solutions

  • Chapter
AIDS, Drugs of Abuse, and the Neuroimmune Axis

Abstract

HIV Associated Dementia (HAD) and peripheral neuropathy result from HIV-1 infection and several parameters impact on their initiation and course. These parameters include properties of the virus such as sequence heterogeneity of the envelope protein and virus and host gene expression in infected and uninfected macrophages in HIV infected individuals. The infection of brain cells such as macrophage/microglia may influence the course and duration of HAD through the elaboration of toxic molecules and viral host by-products of infection. Drugs of abuse complicate our interpretation of the resulting pathologies and affect the molecular and biochemical processes involved in HIV-1 infection and its life cycle. Furthermore, abused drugs may modulate the biology and function of macrophage/microglia as well as other cells in brain. Total HIV-1 virus load in the brain may also impact the clinical consequences of infection. Although specific strains of HIV-1 may inflict HAD by interactions at the molecular level, other mechanisms may operate in the initiation and development of peripheral neuropathy. An important aspect of these studies is the determination of their accuracy, specificity, sensitivity, and reproducibility. We describe important caveats involved in the performance, analysis, and interpretation of the results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Achim, C. L., Wang, R., Miners, D. K., and Wiley, C. A. Brain Viral Burden in HIV Infection. J. Neuropathol. Exp. Neurol. 53, 284–294, 1994

    Article  PubMed  CAS  Google Scholar 

  2. Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, and Solomon L, New evidence on intravenous cocaine use and the risk of infection with HIV-I, Am J of Epidemiol, 134, 1175–1189, 1991

    CAS  Google Scholar 

  3. Antonioli IM, Baumberger C, Yerly S, and Perrin L. V3 sequences in primary HIV-1 infection. AIDS, 9. 11–17, 1995

    Article  PubMed  CAS  Google Scholar 

  4. Aylward, E.H., Henderer, J.D., McArthur, J.C., et al. Reduced basal ganglia volume in HIV-1 associated dementia complex: results for quantitative neuroimaging. Neurology, 43, 2099–2104, 1993

    PubMed  CAS  Google Scholar 

  5. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A. Hefti F: Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995; 373: 339–341

    Article  PubMed  CAS  Google Scholar 

  6. Bell, J. E., Busuttil, A., Ironside, J. W., Rebus, s., Donaldson, Y. K., Simmonds, P., and Peutherer, J. F. Human Immunodeficiency Virus and the Brain: Investigation of Virus Load, and Neuropathologic Changes in Pre-AIDS Subjects. J. Inf. Diseases, 168, 818–824, 1993

    CAS  Google Scholar 

  7. Berger JR, Kumar M, Kumar A, Fernandez JB, and Levin B: Cerebrospinal fluid dopamine in HIV infection, AIDS, 8, 67–71, 1994

    Article  PubMed  CAS  Google Scholar 

  8. Bockstahler, L. E., Werner, T., Festl, H., Weis, S., Einhaeupl, K. M., Erfle, V., and Brack-Werner, R. Distribution of HIV genomic DNA in brains of AIDS patients. Clin Diagn Virol, 3, 61–72, 1995

    Article  PubMed  CAS  Google Scholar 

  9. Boni, J., Emmerich, B. S., Leib, S. L., Wiestler, O. D., Schupbach, J., and Kleihues, P. PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology, 43, 1813 1817, 1993

    Google Scholar 

  10. Brack-Werner, R., Kleinschmidt, A., Ludvigsen, A., Meliert, W., Neumann, M., Heiirnann, R., Khim, M. C. L., Bumy, A., Muller-Lantzsch, N., Stavrou, D., and Volker, E. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS, 6, 273–285, 1992

    Article  PubMed  CAS  Google Scholar 

  11. Brew, B. J., Rosenblum, M., Cronin, K, and Price, R. W. AIDS Dementia Complex and HIV-1 Brain Infection: Clinical-Virological Correlations, Ann Neurol, 38, 563–570, 1995

    Article  PubMed  CAS  Google Scholar 

  12. Briant L. Puel J, Wade CM, Leigh Brown AJ, and Guyader M, Protecting HIV databases- Reply, Nature, 378, 243–244, 1995

    Article  Google Scholar 

  13. Briant L, Wade CM, Puel J, Leigh Brown AJ, and Guyader M, Analysis of envelop sequence variants suggests multiple mechanisms of mother-to-child transmission of HIV-1, J Virol, 69, 3778–3788. 1995

    PubMed  CAS  Google Scholar 

  14. Budka,H. et al.(33 authors).HIV-Associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology. Brain Pathology, 1, 143–152, 1991

    Article  PubMed  CAS  Google Scholar 

  15. Chaisson RE, Bachchetti P, Osmond D, et al, Cocaine use and HIV infection in intravenous drug users in San Francisco, JAMA, 261, 561–565, 1989

    Article  PubMed  CAS  Google Scholar 

  16. Chelley J and Kahn A, RT-PCR and mRNA quantitation, in the polymerase chain reaction, eds. KB Mullis, F Ferré, and RA Gibbs, Birkhauser Press, Boston, 1994, pp. 97–109

    Google Scholar 

  17. Chitwood DD, McCoy CB, Inciardi J, et al, HIV seropositivity of needles from shooting galleries in South Florida, Am J Public Health, 80, 150–152, 1990

    Article  PubMed  CAS  Google Scholar 

  18. Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition of AIDS. JAMA, 258, 1143–1154, 1987

    Article  Google Scholar 

  19. Concha M, Graham NMH, Munoz A, Vlahov D, Royall III, W, Updike M, Nance-Sproson T, Seines OA, and McArthur JC, Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with high prevalence of HIV-I seropositivity, Am J of Epidemiol, 136, 1338–1348, 1992

    CAS  Google Scholar 

  20. Cotter, F. E. The role of polymerase chain reaction in pathology. J. Histotechnology, 17, 253–259, 1994

    CAS  Google Scholar 

  21. Dal Pan, G.J., McArthur, J.H., Aylward, E., Seines, O.A., Nance-Sproson, T.E., Kumar, A.J., Mell its, E.D., and McArthur, J.C. Patterns of cerebral atrophy in HIV-1-infected individuals: Results of a quantitative MRI analysis. Neurology, 42, 2125–2130, 1992

    Google Scholar 

  22. Delassus S, Cheynier R, and Wain-Hobson S, Non-homogeneous distribution of HIV-1 proviruses in the spleen, J of Virol, 66, 5642–5645, 1992

    CAS  Google Scholar 

  23. Eilbot DJ, Peress N, Burger H, et al, HIV-1 in spinal cords of AIDS patients with myelopathy: expression and replication in macrophages, PNAS, 86, 3337–3341, 1989

    Article  Google Scholar 

  24. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, and Goudsmit J, HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies, Virol, 180, 583–590, 1991

    Article  CAS  Google Scholar 

  25. Felsenstein J, Confidence limits on phylogenies: an approach using bootstrap, Evolution, 39, 783–791, 1985

    Article  Google Scholar 

  26. Fujimura, R. K. and Bockstahler L. E. PCR Method for determining ratios of HIV proviral DNA to cellular genomic DNA in brain tissue of HIV-infected patients. J Vir Method, 55, 309–325, 1995

    Article  CAS  Google Scholar 

  27. Goodenow M, Huert T, Saurin W, Kwok S. Sninsky J, and Wain-Hobson S, HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions, J’ of AIDS. 2. 344–352, 1989

    CAS  Google Scholar 

  28. Goodenow M, Huert T, Saurin W, Kwok S. Sninsky J, and Wain-Hobson S, HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions, J’ of AIDS. 2. 344–352, 1989

    CAS  Google Scholar 

  29. Goodkin K: HIV-related complications of the central nervous system. In: Beckett A, Fernandez F, Goodkin K and McDaniel JS. HIV-related neuropsychiatrie complications and treatments. An AIDS Training Curriculum for Psychiatrists. Commission on AIDS, M. Forstein (Chair), American Psychiatric Association, Washington, DC, 1995, pp. 1–64

    Google Scholar 

  30. Goswami KK, Miller RF, Harrison MJ, Hamel DJ, Daniels RS, and Tedder RS, Expression of HIV-1 in the CSF detected by the PCR and its correlation with CNS disease, AIDS, 5, 797–803, 1991

    Article  PubMed  CAS  Google Scholar 

  31. Grez M, Dietrich U, Balfe P, von Briesen H, Maniar JK, Mahambre G, Delwart EL, Mullins JI, and Waigmann HR, Genetic analysis of HIV-1 and -2 mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from single ancestor for each of these viruses, J Virol, 68, 2161–2168, 1994

    PubMed  CAS  Google Scholar 

  32. Gribskov M and Devereux J, Sequence Analysis Primer, WH Freeman and Co, New York, 1992

    Google Scholar 

  33. Groenink M, Andeweg AC, Fouchier RAM, Broersen S, Van der Jagt RCM, Schuitemaker H, De Goede REY, Bosch ML, Huiseman HG, and Tersmette M, Phenotype associated env gene variation among eight related HIV-1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain, J Virol, 66, 6175–6180, 1992

    PubMed  CAS  Google Scholar 

  34. Halm BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wonb Staal F, Gallo RC, Parks ES, and Parks WP, Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS, Science, 232, 1548–1553, 1986

    Article  Google Scholar 

  35. Hasegawa M. Kishino H, and Yano T, Dating the human ape splitting by a molecular clock of mitochondrial DNA, J Molec Evol, 22, 160–174, 1985

    Article  PubMed  Google Scholar 

  36. Higgins DG, Bleasby AJ, and Fuchs R, Clustal V: improved software for multiple sequence alignment, Comput Appl Biosci, 8, 189–191, 1992

    PubMed  CAS  Google Scholar 

  37. Howell RM, Fitzgibbon JE, Noe M, Ren Z, Gocke DJ, Schartzer TA, and Dubin DT, In vivo sequence variation of the HIV-1 env gene: evidence for recombination among variants found in a single individual, AIDS Res and Hum Retrov, 7, 869–876, 1991

    Google Scholar 

  38. Kalisch ML, Baldwin A, Raktham S, Wasi C, Luo C, Schochetman G, Mastro TD, Young N, Vanichseni S, Rübsamen-Waigmann H, von Briesen H, Mullins J, Delwart E, Herring B, Esparza J, Heyward WL, and Osmmanov S, The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials, AIDS 9, 851–857, 1995

    Article  Google Scholar 

  39. Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715723

    Google Scholar 

  40. Korber BTM, Kunstman KJ, Patterson BK, et al, Genetic differences between blood-and brain-derived viral sequences from HIV-1-infected patients: evidence for conserved elements in the V3 region of the envelope protein of brain-derived sequences, J of Virol 68, 7467–7481, 1994

    CAS  Google Scholar 

  41. Korber BTM, Learn G, Mullins JI Hahn BH, and Wolinsky SM, Protecting HIV databases, Nature, 378, 242–243, 1995.

    Article  PubMed  CAS  Google Scholar 

  42. Kuiken CL, Goudsmit J, Weiller GF, Armstrong, Hartman S, Portegies P, Dekker J, and Cornelissen M, Differences in HIV-1 V3 sequences from patients with and without AIDS dementia complex, J of Gen Virol, 76, 175–180, 1995

    Article  CAS  Google Scholar 

  43. Kwok S, Procedures to minimize PCR-product carry-over, in PCR-protocols and applications- A Laboratory Manual, 1990

    Google Scholar 

  44. Learn G, Korber BTM, Foley B, Hahn BH, Wolinsky SM, and Mullins JI, Maintaining the integrity of human immunodeficiency virus sequence databases, J of Viral, submitted, 1995

    Google Scholar 

  45. Lipton SA, Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology, 42, 1403–1405, 1992

    PubMed  CAS  Google Scholar 

  46. Louwagie J, McCutchan F, van der Groen G. et al. Genetic comparison of HIV-1 isolates from Africa. Europe, and North America. AIDS Res Hum Retroviruses, 8, 147–9, 1992

    Google Scholar 

  47. Louwagie J, McCutchan FE, Peeters M. et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes, AIDS, 7, 769–80, 1993

    Article  PubMed  CAS  Google Scholar 

  48. Masliah, E. Achim, C. L., Ge, N., De Teresa, R., Terry, R. D., and Wiley, C. A. Spectrum of Human Immunodeficiency Virus-associated Neocortical Damage. Ann Neurol, 32, 321–329, 1992

    CAS  Google Scholar 

  49. McCoy CB, Shapshak P, Rivers JE, McCoy HV, Weatherby NL, Chitwood DD, Shah SM, Inciardi JA, McBride DC, and Watters JK, The risks of injection practices and compliance to risk reduction protocols in the prevention of HIV-1 among injecting drug users, J of AIDS, 7, 773–776, 1994

    CAS  Google Scholar 

  50. McCutchen FE, Hegerich PA, Brennan TP, Phanuphak P, Singharaj P, Jugsudee A, Berman PW, Gray AM, Fowler AK, and Burke DS, Genetic variants of HIV-1 in Thailand, AIDS Res and Hu Retr, 8, 1887–1895 1992

    Article  Google Scholar 

  51. KcKegney FP, O’Dowd MA, Feiner C, et al, A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients, AIDS, 4, 565–569, 1990

    Article  Google Scholar 

  52. Leitner T, Escanilla D, Marquina S, Wahlberg J, Bronstrom C, Hansson HB, Uhlen M, and Albert J, Biological and molecular characterization of subtype D, G, and A/D recombinant HIV transmission in Sweden, Virology, 209, 136–146, 1995

    Article  PubMed  CAS  Google Scholar 

  53. McNearney T, Westervelt P, Thielan BJ, Trowbridge DB, Garcia J, Whittier R, and Ratner L, Limited sequence heterogeneity among biologically distinct HIV-1 isolates from individuals involved in a clustered infectious outbreak, PNAS, 87, 1917–1921, 1990

    Article  PubMed  CAS  Google Scholar 

  54. Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, Sninsky J, Morfeldt-Mânson L, Asjö, and Wain-Hobson S, Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations, Cell, 58, 901–910, 1989

    Article  PubMed  CAS  Google Scholar 

  55. Meyerhans A, Vartanian JP, and Wain-Hobson S, DNA recombination during PCR, Nucleic Acids Res, 18, 1687–1691, 1990.

    Article  PubMed  CAS  Google Scholar 

  56. Mildvan D, Machado SG, Wilets, I, Grossberg SE: Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 1992; 339: 453456.

    Google Scholar 

  57. Myers G, Berzofsky JA, Korber B, Smith RF, Pavlakis GN. Human retroviruses and AIDS. Los Alamos, NM: Dept. of Theoretical Biology and Biophysics. Los Alamos National Laboratory, 1993

    Google Scholar 

  58. Myers G and Korber B, The Future of HIV, in The Evolutionary Biology of Viruses, ed. S.S. Morse, Raven Press, Ltd., New York, 1994, Chapter 10, pp. 211–232.

    Google Scholar 

  59. Monken CE, Wu B, and Srinivasan A, High resolution analysis of HIV-1 quasispecies in the brain, AIDS, 9, 345–349, 1995

    PubMed  CAS  Google Scholar 

  60. Monken CE, Wu B, and Srinivasan A, High resolution analysis of HIV-1 quasispecies in the brain, AIDS, 9, 345–349, 1995

    PubMed  CAS  Google Scholar 

  61. Monken CE, Wu B, and Srinivasan A, High resolution analysis of HIV-1 quasispecies in the brain, AIDS, 9, 345–349, 1995

    PubMed  CAS  Google Scholar 

  62. Palmer DL, Hjelle BL, Wiley CA, Allen S, Wachsman W, Mills RG, Davis LE, and Merlin TL, HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells, Am J of Med, 97, 289–295, 1994

    Article  CAS  Google Scholar 

  63. Pang, S., Koyanagi, Y., Miles, S., Wiley, C., Vinters, H. V., and Chen I. S. Y. High levels of unintegrated HIV-1 DNA in brain tissue of AIDs dementia patients, Nature, 343, 85–89, 1990

    Article  PubMed  CAS  Google Scholar 

  64. Pang S, Vinters HV, Akashi T, O’Brien WA, and Chen ISY, HIV-1 Env sequence variation in brain tissue of patients with AIDS-related neurologic disease, J of AIDS, 4, 1082–1092, 1991

    CAS  Google Scholar 

  65. Pert, C. B., Ruff, M. R., Ruscetti, F., Farrar, W. L., and Hill, J. M. HIV Receptor in Brain and Deduced Peptides That Block Viral Infectivity. in Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS. Bridge, T. P. et al. (eds) Raven Press, New York, 1988; pp 73–83

    Google Scholar 

  66. Petito, C. K., Cho, E-S., Lemann, W., Navia, B.A., and Price, R. W. Neuropathology of Acquired Immunodeficiency Syndrome (AIDS): Autopsy Review. J Neuropathol Exp Neurol, 45, 635–646, 1986

    Article  PubMed  CAS  Google Scholar 

  67. Petito CK and Roberts B, Evidence of apoptotic cell death in HIV encephalitis, Am J of Pathol, 146, 1121–1130, 1995

    CAS  Google Scholar 

  68. Pieniazek D, Janini LM, Ramos A, Tanuri A, Schechter M, Peralta JM, Vicente ACP, Pieniazek NJ, Schochetman G, and Rayfield MA, HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic, Emerging Infect Dis, 1, 86–88, 1995

    Article  PubMed  CAS  Google Scholar 

  69. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Dewey R, and Chesebro B. Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence, in HIV and Dementia, eds. MBA Oldstone and L Vitkovic (1995) Cur Topics in Microb and Immunol, 202, pp.89–104

    Google Scholar 

  70. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, and Chesebro B, Demented and nondemented patients with /AIDS differ in brain-derived HIV-1, envelope sequences, J of Virology, 68, 4643–4649, 1994

    CAS  Google Scholar 

  71. Presley LA and Budowle B, The Application of PCR-based technologies to forensic analysis, in PCR Technology Current Innovations, ed. HG Griffin and AM Griffin, CRC Press, Boca Raton, 1994, pp. 259–276

    Google Scholar 

  72. Ratner L, Haseltine W, Petarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitwhoen EA, Baumeister K, Ivanoff L, Petteway SR, Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo RC, and Wong-Staal F, Complete nucleotide sequence of the AIDS virus HTLV-III, Nature, 313, 277–285, 1985

    Article  PubMed  CAS  Google Scholar 

  73. Resnick L, Berger JR, Shapshak P, Tourtellotte WW: Early penetration of the blood-brain-barrier by HTLV-II1/LAV, Neurology, 38, 9–15, 1988

    PubMed  CAS  Google Scholar 

  74. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ: Cocaine receptors on dopamine transporters are related to self administration of cocaine. Science 1987; 237: 1219–1223.

    Article  PubMed  CAS  Google Scholar 

  75. Robertson DL, Hahn BH, and Sharp PM, Recombination in AIDS viruses, J of Molec Evol, 40, 249–259, 1995

    Article  CAS  Google Scholar 

  76. Robertson DL, Sharp PM, McCutchan FE, and Hahn BH. Recombination in HIV-1, Nature, 3374, 124–126, 1995

    Article  Google Scholar 

  77. Saag MS, Hahn BH, Gibbons J, Li Y, Parks E, Parks WP, and Shaw GM, Extensive variation of HIV-1 in vivo, Science, 334, 440–444, 1989

    Google Scholar 

  78. Sabino EC, Shpaer EG, Morgado MG, Mullins JI, and Mayer A, The identification of HIV-1 envelope genes recombinant between subtypes B and F, in two epidemiologically linked individuals from Brazil, J of Virology, 68. 6340–6346, 1995

    Google Scholar 

  79. Saitou N and Nei M, The neighbor-joining method: a new method for reconstructing phylogenetic trees, Mol Biol Evol, 4, 406–425, 1987

    PubMed  CAS  Google Scholar 

  80. Saksena NK, Dwyer D, and Barré-Sinoussi F, A “sentinel” technique for monitoring viral aerosol contamination, J of Infect Dis, 164, 1021–1022, 1991

    Article  CAS  Google Scholar 

  81. Sala M, Zambruno G, Vartanian JP, Marconi A, Bertazzoni U, and Wain—Hobson S, Spatial discontinuities in HIV-1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection, J of Virol, 68, 5280–5283, 1994

    CAS  Google Scholar 

  82. Sanchez-Ramos JR, Neurological Emergencies related to drugs of dependence, in Urgent and Emergent Neurology, ed. WJ Wiener, Futura Press, NY, 1995, pp. 487–507

    Google Scholar 

  83. Saphier D: Central nervous system effects of interferon-a in man and animals. Presented at the Psychoneuroimmunology Research Society Meeting. 11/16/94–11/20/94, Key Biscayne, FL

    Google Scholar 

  84. Shah SM, Shapshak P, Rivers JE, Weatherby NL, Xin KQ, Stewart RV, Chitwood DD, Page JB, Mash DC, Vlahov D, and McCoy CB, Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: preliminary laboratory results, J of AIDS, in press, 1996

    Google Scholar 

  85. Shapshak P, Nagano I, Xin KQ, Bradley W, McCoy CB, Sun NCJ, Stewart NCJ, Yoshioka M, Petito C. Goodkin K, Douyon R, Srivastava AK, Crandall KA, HIV-1 heterogeneity and cytokines: neuropathogenesis, in The Brain Immune Axis and Substance Abuse, B. Sharp, T. Eisenstein, J. Madden, and H. Friedman, eds. Adv. in Exp. Med. And Biol., vol. 373, Chapter 31, pp.225–236, 1995

    Google Scholar 

  86. Shapshak P, Sun N, Resnick L, Hsu M. Tourtellotte WW, Schmid P, Conrad A, M. Fiala, and D. T. Imagawa, The detection of HIV by in situ hybridization. Modern Pathology, 3, 146–153, 1990

    PubMed  CAS  Google Scholar 

  87. Shapshak P, Sun NCJ, Yoshioka M, Shah SM, Schiller PC, Resnick L, and Imagawa DT, Detection of HIV-1 in the CNS: expiant culture, immunocytochemical, and in situ hybridization techniques, AIDS, 6, 915–923, 1992

    Article  PubMed  CAS  Google Scholar 

  88. Shapshak P, Tourtellotte WW, Resnick L, Osborne MA, Schmid P, Lee M, Rubinshtein G, Imagawa DT, Mitsuyasu R, Gottlieb M, Gallo RC: HTLV III can cross the blood brain barrier. The Fourth Colloquium in Biological Sciences, Blood Brain Transfer. Annals of the NY Academy of Sci, 529, 291–294, 1988

    Article  Google Scholar 

  89. Shapshak P, Tourtellotte WW, Wolman M, Verity N, Verity MA, Schmid P, Syndulko K, Bedows E, Boostanfar R, Darvish M, Nakamura S, Tomiyasu U: Search for virus nucleic acid sequences in post-mortem human brain tissue using in situ hybridization technology with cloned probes: Some solutions and results on PML and SSPE tissue. J of Neurosci Res 16: 281–301, 1986

    Article  CAS  Google Scholar 

  90. Shapshak P, Yoshioka M, Sun NCJ, and Schiller P, The use of combined immunocytochemistry and in situ hybridization to detect HIV-1 in formalin fixed paraffin embedded brain tissue, Modern Pathology, 5, 649–654, 1992

    PubMed  CAS  Google Scholar 

  91. Shaw, G. M. et al. (14 authors) HTLV-III Infection in Brains of Children and Adults with AIDS Encephalopathy, Science, 227, 177–182, 1985

    Article  PubMed  CAS  Google Scholar 

  92. Silberstein CH, McKegney FP, O’Dowd MA, et al, Aprospective longitudinal study of neuropshychological and psychosocial factors in individuals at risk for HTLV-III/LAV infection in a methadone program: preliminary findings, Int J of Neurosci, 32, 669–676, 1987

    Article  CAS  Google Scholar 

  93. Simmonds P Balfe P, Ludlam CA, Bishop JO, and Brown AJL, Analysis of sequence diversity in hypervariable regions of the external glycoprotein of HIV-1, J of Virol, 64, 5840–5850, 1990

    CAS  Google Scholar 

  94. Sinclair, E., Gray, F., Ciardi, A., and Scaravilli, F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J. Neuropathol. Exp. Neurol. 1994; 53: 43–50

    Article  PubMed  CAS  Google Scholar 

  95. Singer EJ, Syndulko K, Fahy-Chandon BN, Shapshak P, Resnick L, Schmid P, Conrad AJ. and Tourtellotte WW, Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1, AIDS, 8, 197–204, 1994.

    Article  PubMed  CAS  Google Scholar 

  96. Sippy BD, Hofman FM. Wallach D. and Hinton DR, Increased expression of TNF-a receptors in the brains of patients with AIDS, J of AIDS, 10, 511–521, 1995

    CAS  Google Scholar 

  97. Steuler H, Storch-Hagenlocher B, and Wildemann B, Distinct populations of HIV-1 in blood and CSF, AIDS Res and Hum Retrovir, 8, 53–59, 1992

    Article  CAS  Google Scholar 

  98. Stewart RV, Shapshak P, Matthews A, Bradley W, Sun NCJ, Mash DC, Perez M. Shah SM, Yoshioka M, Nagano I, Bitonte RA, Sundar KS, Fiala M, and Arguello JC, Effects of cocaethylene and HIV-1 infection on surface marker expression of macrophages isolated from human brain using antibody coated magnetic beads: a preliminary study, submitted, 1996

    Google Scholar 

  99. Strunnikova N, Ray SC, Lisingston RA, Rubalcaba E, and RP Viscidi, Convergent evolution within the V3 loop domain of HIV type 1 in association with disease progression, J of Virol, 69, 7548–7558, 1995

    CAS  Google Scholar 

  100. Swofford DS, PAUP* 4.0 d21, Sinauer Assoc, Sunderland, MA, 1995

    Google Scholar 

  101. Sun NCJ, Shapshak P, Lachant NA, Hsu MY, Sieger L, Schmid P, Beall G, and Imagawa DT: Bone marrow examination in patients with AIDS and AIDS related complex (ARC): morphologic and in situ hybridization studies: Am J of Clin Pathol, 92, 589–594, 1989

    CAS  Google Scholar 

  102. Tourtellotte WW, Schmid P, Pick P, Verity N. Martinez S, Shapshak P: Quest for a reliable, valid, and sensitive in situ hybridization procedure to detect viral nucleic acids in the central nervous system. Neurochem Res 12 /6: 565–571, 1987

    Article  PubMed  CAS  Google Scholar 

  103. Tourtellotte WW, Singer E, Syndulko K, Shapshak P, and Resnick L, Intra-blood-brain-barrier IgG synthesis in HIV, in Enzymes as Targets for Drug Design, MG Palfreyman, PP McCann, W Lovenberg, JG Temple, A Sjoerdsma, Merrell Dow Research Institute, Academic Press, San Diego, pp. 211–217, 1990

    Google Scholar 

  104. Tourtellotte WW, Verity N, Schmid P, Martinez S, Shapshak P: Covalent binding of formalin fixed paraffin embedded brain tissue sections to glass slides suitable for in situ hybridization. J Virol Methods 15: 87–99, 1987

    Article  PubMed  CAS  Google Scholar 

  105. Tyor WR, Glass JD, Griffin JW, et al, Cytokine expression in the brain during AIDS, Aim Neurol, 31, 349–360, 1992

    Article  CAS  Google Scholar 

  106. Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, and Griffin DE, Unifying hypothesis for the pathogenesis of HIV-associated Dementia Complex, Vacuolar myelopathy, and sensory neuropathy, J of AIDS and Human Retrovirology, 9, 379–388, 1995

    CAS  Google Scholar 

  107. Vazeux, R., Lacroix-Ciaudo, C., Blanche, S., Cumont, M-C., Henin, D., Gray, F., Boccon-Gibod, L. and Tardieu, M. Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am. J. Pathol. 1992; 140: 137–144

    PubMed  CAS  Google Scholar 

  108. Vitkovic L, da Cunha A, and Tyor WR, Cytokine expression and pathogenesis in AIDS brain, in “HIV, AIDS and the Brain”, eds. RW Price and SW Perry, Raven Press Ltd, New York, 1994

    Google Scholar 

  109. Wain-Hobson S, Is antigenic variation of HIV important for AIDS and what might be expected in the future? in The Evolutionary Biology of Viruses, ed. S.S. Morse, Raven Press, Ltd., New York, 1994, Chapter 9, pp. 185–209

    Google Scholar 

  110. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, and Griffin DE, Intracerebral cytokine messenger RNA expression in AIDS dementia, Ann Neurol, 33, 576–582, 1993

    Article  PubMed  CAS  Google Scholar 

  111. Wieser B, Peress N, La Neve D, Eilbott DJ, Seidman R, and Burger H, HIV-1 expression in the CNS correlates directly with extent of disease, PNAS, 87, 3997–4001, 1990

    Article  Google Scholar 

  112. Wiley, C. A., Masliah, E., and Achim, C. L. Measurement of CNS HIV burden and its association with neurologic damage. Adv Neuroimmunol 1994; 4: 319–325

    Article  PubMed  CAS  Google Scholar 

  113. Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., and Oldstone, M. B. A. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 1986; 83: 7089–7093

    Article  PubMed  CAS  Google Scholar 

  114. Xin KQ, Ma XH, Crandall KA, Bukawa KH, Ishikasubo Y, Kawamoto S, and Okuda K, Dual infection with HIV-1 Thai subtype B and E, The Lancet, 346, 1372–1995, 1995

    Article  CAS  Google Scholar 

  115. Xin KQ, Shapshak P, Kawamoto S, Nagano I, McCoy CB, and Okuda K, Highly divergent env sequences of HIV-1 B subtype with two novel V3 loop motifs detected in an AIDS patient in Miami, AIDS Res and Hu Retrov, Sequ Note, 11, 1139–1141, 1995

    CAS  Google Scholar 

  116. Yap EPH, Lo YMO, Fleming KA, and McGee JO’D, False-positives and contamination in PCR, in PCR Technology Current Innovations, ed. HG Griffin and AM Griffin, CRC Press, Boca Raton, 1994, pp. 249–258

    Google Scholar 

  117. Yoshioka M, Bradley WG, Shapshak P, Nagano I, Stewart RV, Xin KQ, Srivastava AK, and Nakamura S. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases, Adv. in Neuroimm, 5, 335–358, 1995

    Google Scholar 

  118. Yoshioka M, Shapshak P, Nakamura S Nagano I, Nelson SJ, and Kogure K, TNF producing cells in AIDS brain, Neurology, 42 (suppl. 3), 236, 1992

    Google Scholar 

  119. Yoshioka M, Shapshak P, Srivastava AK, Nelson SJ, Bradley WG, Berger JR, Rhodes RH, `Sun NCJ, Stewart RV, and Nakamura, Role of immune activation, interleukin-6 expression and HIV-1 in the pathology of dorsal root ganglia of patients with AIDS, Neurology, 44, 1120–1130, 1994

    PubMed  CAS  Google Scholar 

  120. Yoshioka M, Shapshak P, Sun NCJ, Svenningsson A, Nelson S, Resnick L. Tate L, Ferritin immunoreactivity in microglial nodules in AIDS brain, Acta Neuropathologica, 84, 297–306, 1992

    Article  PubMed  CAS  Google Scholar 

  121. Young LS, The polymerase chain reaction: a new tool for the histopathologist, in Molecular Biology in Histopathology, ed J Crocker, J Wiley Publ, New York, 1994, pp. 39–55

    Google Scholar 

  122. Zhu T, Wang N, Carr A, Wolinsky S, and Ho DD, Evidence for coinfection by multiple strains of HIV-1 subtype B in an acute seroconverter, J of Virol, 69, 1324–1327, 1995

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Shapshak .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Plenum Press, New York

About this chapter

Cite this chapter

Shapshak, P. et al. (1996). Hiv-1 Neuropathogenesis and Abused Drugs. In: Friedman, H., Eisenstein, T.K., Madden, J., Sharp, B.M. (eds) AIDS, Drugs of Abuse, and the Neuroimmune Axis. Advances in Experimental Medicine and Biology, vol 402. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0407-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0407-4_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-8038-2

  • Online ISBN: 978-1-4613-0407-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics